- Home
- INGR vs ROIV Comparison
INGR vs ROIV Comparison
Compare INGR & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGR
- ROIV
- Stock Information
- Founded
- INGR 1906
- ROIV 2014
- Country
- INGR United States
- ROIV United Kingdom
- Employees
- INGR N/A
- ROIV N/A
- Industry
- INGR Packaged Foods
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- INGR Consumer Staples
- ROIV Health Care
- Exchange
- INGR Nasdaq
- ROIV Nasdaq
- Market Cap
- INGR 8.6B
- ROIV 8.6B
- IPO Year
- INGR 1997
- ROIV N/A
- Fundamental
- Price
- INGR $123.77
- ROIV $15.28
- Analyst Decision
- INGR Hold
- ROIV Strong Buy
- Analyst Count
- INGR 5
- ROIV 4
- Target Price
- INGR $151.40
- ROIV $15.50
- AVG Volume (30 Days)
- INGR 445.1K
- ROIV 7.8M
- Earning Date
- INGR 11-04-2025
- ROIV 11-11-2025
- Dividend Yield
- INGR 2.58%
- ROIV N/A
- EPS Growth
- INGR 4.50
- ROIV N/A
- EPS
- INGR 10.23
- ROIV N/A
- Revenue
- INGR $7,316,000,000.00
- ROIV $23,233,000.00
- Revenue This Year
- INGR $2.02
- ROIV N/A
- Revenue Next Year
- INGR $2.45
- ROIV $281.14
- P/E Ratio
- INGR $12.14
- ROIV N/A
- Revenue Growth
- INGR N/A
- ROIV N/A
- 52 Week Low
- INGR $120.51
- ROIV $8.73
- 52 Week High
- INGR $155.44
- ROIV $16.05
- Technical
- Relative Strength Index (RSI)
- INGR 36.63
- ROIV 82.00
- Support Level
- INGR $123.36
- ROIV $13.81
- Resistance Level
- INGR $127.19
- ROIV $14.48
- Average True Range (ATR)
- INGR 1.95
- ROIV 0.47
- MACD
- INGR -0.26
- ROIV 0.22
- Stochastic Oscillator
- INGR 5.76
- ROIV 81.67
About INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.